Akums Drugs and Pharmaceuticals Limited (BOM:544222)
India flag India · Delayed Price · Currency is INR
450.65
-13.70 (-2.95%)
At close: Feb 13, 2026

BOM:544222 Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
69,10374,479----
Enterprise Value
53,65871,969----
Last Close Price
450.65474.60----
PE Ratio
21.7222.02----
PS Ratio
1.601.81----
PB Ratio
2.182.43----
P/TBV Ratio
2.202.45----
P/FCF Ratio
-38.61----
P/OCF Ratio
-16.01----
EV/Sales Ratio
1.241.75----
EV/EBITDA Ratio
10.0015.76----
EV/EBIT Ratio
14.1222.60----
EV/FCF Ratio
-37.31----
Debt / Equity Ratio
0.030.030.790.860.640.15
Debt / EBITDA Ratio
0.170.191.162.070.980.45
Debt / FCF Ratio
-0.463.03--2.75
Net Debt / Equity Ratio
-0.49-0.160.400.650.480.05
Net Debt / EBITDA Ratio
-2.92-1.070.601.630.740.16
Net Debt / FCF Ratio
--2.531.54-3.11-1.320.94
Asset Turnover
-1.081.231.151.40-
Inventory Turnover
-3.813.853.244.19-
Quick Ratio
-1.510.920.800.781.07
Current Ratio
-2.551.601.521.492.00
Return on Equity (ROE)
-18.17%0.11%14.51%-33.18%-
Return on Assets (ROA)
-5.22%6.72%3.74%7.54%-
Return on Invested Capital (ROIC)
22.88%17.70%33.07%11.64%34.07%17.35%
Return on Capital Employed (ROCE)
-9.90%15.80%9.50%17.60%14.20%
Earnings Yield
4.60%4.54%----
FCF Yield
-2.59%----
Buyback Yield / Dilution
-4.01%-4.58%----
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.